As of 2024-12-14, the EV/EBITDA ratio of Deltex Medical Group PLC (DEMG.L) is -7.45. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DEMG.L's latest enterprise value is 3.17 mil GBP. DEMG.L's TTM EBITDA according to its financial statements is -0.43 mil GBP. Dividing these 2 quantities gives us the above DEMG.L EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.7x - 11.2x | 9.4x |
| Forward P/E multiples | 12.8x - 14.2x | 13.6x |
| Fair Price | (0.38) - (0.34) | (0.35) |
| Upside | -569.3% - -524.9% | -532.2% |
| Date | EV/EBITDA |
| 2024-12-11 | -7.27 |
| 2024-12-10 | -7.45 |
| 2024-12-09 | -7.45 |
| 2024-12-06 | -7.45 |
| 2024-12-05 | -7.45 |
| 2024-12-04 | -7.45 |
| 2024-12-03 | -7.45 |
| 2024-12-02 | -7.45 |
| 2024-11-29 | -7.45 |
| 2024-11-28 | -7.45 |
| 2024-11-27 | -7.45 |
| 2024-11-26 | -7.45 |
| 2024-11-25 | -7.45 |
| 2024-11-22 | -7.45 |
| 2024-11-21 | -7.45 |
| 2024-11-20 | -7.23 |
| 2024-11-19 | -7.67 |
| 2024-11-18 | -7.67 |
| 2024-11-15 | -7.67 |
| 2024-11-14 | -7.67 |
| 2024-11-13 | -7.67 |
| 2024-11-12 | -7.67 |
| 2024-11-11 | -7.67 |
| 2024-11-08 | -7.90 |
| 2024-11-07 | -7.90 |
| 2024-11-06 | -7.90 |
| 2024-11-05 | -7.90 |
| 2024-11-04 | -7.90 |
| 2024-11-01 | -8.12 |
| 2024-10-31 | -8.12 |
| 2024-10-30 | -8.56 |
| 2024-10-29 | -8.56 |
| 2024-10-28 | -8.56 |
| 2024-10-25 | -8.56 |
| 2024-10-24 | -8.56 |
| 2024-10-23 | -8.56 |
| 2024-10-22 | -8.56 |
| 2024-10-21 | -8.56 |
| 2024-10-18 | -8.56 |
| 2024-10-17 | -8.56 |
| 2024-10-16 | -8.56 |
| 2024-10-15 | -8.56 |
| 2024-10-14 | -8.56 |
| 2024-10-11 | -8.56 |
| 2024-10-10 | -8.56 |
| 2024-10-09 | -8.56 |
| 2024-10-08 | -8.56 |
| 2024-10-07 | -8.56 |
| 2024-10-04 | -8.56 |
| 2024-10-03 | -8.56 |